Bharat Biotech International Limited (BBIL/Bharat Biotech),Hyderabad,India is a multidimensional biotechnology company specialising in product oriented research, development and manufacturing of vaccines and biotherapeutics. Bharat Biotech established in the year 1996 by Dr. Krishna M.Ella and Mrs. Suchitra K.Ella as the founder Directors,is engaged in developing next generation vaccines and bio therapeutics through innovative and collaborative research. BBILs state of the art manufacturing plant is the largest of its kind in Asia Pacific. The first bio pharma facility in the country to be audited and approved by Korean food and drugs administration (KFDA),it sprawls over a picturesque campus at Genome valley,Hyderabad. Built with an investment of over INR 1000 million,the facilitys manufacturing,control procedures and protocols, conform to the stringent standards laid down by internationally recognized institutions such as USFDA,UKMCA and WHO. Bharat Biotech has set new benchmarks in innovation and quality that epitomizes the tremendous progress of Indian biotechnology in the global arena.

Bharat Biotech International Limited has adopted the policy to produce pure,safe and effective high quality biologicals through recombinant DNA and other appropriate technologies toward the creation of healthier tomorrow.